Congress mandates coverage for life-saving specialty formulas for rare metabolic disorders
H.R. 5684 — Medical Foods and Formulas Access Act of 2025 · Filed by Jim McGovern (D-MA) · 14 cosponsors · Introduced Oct 3, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires Medicare, Medicaid, CHIP, and federal employee health plans to cover specialized medical foods and formulas—including amino acids and vitamins—prescribed by doctors for patients with inherited metabolic disorders, malabsorption conditions, and severe food allergies. These formulas are life-sustaining treatments for conditions like short bowel syndrome and urea cycle disorders; the bill also encourages private insurers to do the same.
Why we flagged it
The bill's core function is to mandate coverage of specialized medical foods under federal health programs for patients with rare metabolic and digestive disorders. It is a straightforward healthcare access measure, not a tax provision, deregulation, or commemorative act.
What the text implies
- Effective dates are staggered (1–3 years post-enactment), creating a multi-year implementation window that may delay access for some patients while states adjust Medicaid plans.
- The bill defines 'medically necessary food' narrowly (excluding gluten-free foods for celiac disease, diabetes management foods) which may leave some patients with related conditions uncovered despite similar medical need.
The full analysis lists 5 implications of this text.
Who stands to gain
specialty medical food manufacturers; enteral nutrition companies; amino acid and vitamin supplement producers